Piper Sandler analyst Korinne Wolfmeyer assigned a Hold rating to Hims & Hers Health (HIMS – Research Report) today and set a price target of $9.00. The company’s shares closed yesterday at $9.64.
Wolfmeyer covers the Consumer Cyclical sector, focusing on stocks such as Inter Parfums, Ulta Beauty, and e.l.f. Beauty. According to TipRanks, Wolfmeyer has an average return of 2.1% and a 54.95% success rate on recommended stocks.
Hims & Hers Health has an analyst consensus of Moderate Buy, with a price target consensus of $10.83.
See Insiders’ Hot Stocks on TipRanks >>
Based on Hims & Hers Health’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $226.7 million and a GAAP net loss of $7.57 million. In comparison, last year the company earned a revenue of $144.84 million and had a GAAP net loss of $18.84 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Hims & Hers Health (HIMS) Company Description:
Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.
Read More on HIMS:
